Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.25Price to Sales
VS
Market
Sector
Industry
History
$ 6.63Close
$ 5.1 - $ 8.78 52-Week Range
Ticker Information
Ticker
LFCRCompany Name
LIFECORE BIOMEDICAL INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQLIFECORE BIOMEDICAL INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LFCR - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 290.29M | 2.25 | $ 128.87M |
| 3/31/2025 | $ 252.14M | 1.93 | $ 130.31M |
| 12/31/2024 | $ 246.59M | 1.88 | $ 130.86M |
| 9/30/2024 | $ 166.23M | 1.29 | $ 128.44M |
| 6/30/2024 | $ 195.89M | 1.53 | $ 128.26M |
| 3/31/2024 | $ 154.66M | 1.33 | $ 115.9M |
| 6/30/2023 | $ 153.04M | 1.48 | $ 103.27M |
| 3/31/2023 | $ 247.13M | 1.57 | $ 157.38M |
| 12/31/2022 | $ 154.93M | 0.85 | $ 182.86M |
| 9/30/2022 | $ 243.87M | 0.89 | $ 273.55M |
Key Performance Insights, Last 5 Years
- LIFECORE BIOMEDICAL INC's latest trailing twelve months (TTM) P/S stands at 0.55.
- Over the past 5 years, LIFECORE BIOMEDICAL INC's average P/S has been 1.18.
- The median P/S for LIFECORE BIOMEDICAL INC during this period was 1.29
- LIFECORE BIOMEDICAL INC reached its highest P/S over the past 5 years at 2.25.
- The lowest P/S recorded by LIFECORE BIOMEDICAL INC in the same timeframe 0.52
LIFECORE BIOMEDICAL INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for LIFECORE BIOMEDICAL INC is calculated as follows: Market Cap [ $ 316.69M ] / Revenues [ $ 575.61M ]
(=) P/S [ 0.55 ] LFCR - Price to Sales, Last 5 years
0.52
Minimum
Sep 30, 2021
2.25
Maximum
Jun 30, 2025
1.18
Average
1.29
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |